Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Digestive Diseases (Basel, Switzerland)|January 20, 1999
Health-related quality of life outcomes of omeprazole versus ranitidine in poorly responsive symptomatic gastroesophageal reflux diseaseD A Revicki, S Sorensen, P N Maton, et al.
Archives of Emergency Medicine|December 1, 1993
Predictors of work satisfaction among SHOs during accident and emergency medicine trainingJ Heyworth, T W Whitley, E J Allison, et al.
International Clinical Psychopharmacology|September 19, 2000
Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sampleS H Hamilton, E T Edgell, D A Revicki, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 1, 1997
Evidence for reliability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV)A W Wu, D A Revicki, D Jacobson, et al.
CNS Drugs|July 24, 2001
The economics of selective serotonin reuptake inhibitors in depression: a critical reviewL Frank, D A Revicki, S V Sorensen, et al.
Archives of Emergency Medicine|December 1, 1993
Correlates of work-related stress among consultants and senior registrars in accident and emergency medicineJ Heyworth, T W Whitley, E J Allison, et al.
QRB. Quality Review Bulletin|November 1, 1990
Reliability of ratings of anesthesia's contribution to adverse surgical outcomesD A Revicki, D N Klaucke, R E Brown, et al.
Journal of Affective Disorders|July 21, 1998
Health-related quality of life assessment in euthymic and depressed patients with bipolar disorder. Psychometric performance of four self-report measuresN K Leidy, C Palmer, M Murray, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 31, 1997
Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trialS H Hamilton, D A Revicki, L A Genduso, et al.
The Journal of Family Practice|December 29, 1998
Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatmentD A Revicki, G E Simon, K Chan, et al.
Pageof 11